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Amsterdam Public Health Institute, VU University Medical Center and GGZinGeest, Amsterdam, The Netherlands
ABSTRACT
Aims: The aim of this study was to elicit the preference of patients with an anxiety disorder regarding
treatment modalities. Understanding patients’ preferences could help optimize treatment uptake and
adherence to therapeutic interventions.
Materials and methods: A discrete-choice experiment was used to elicit patients’ preferences with
regard to four treatment characteristics: waiting time until first treatment, intensity of treatment, face-
to-face vs digital treatment, and group size. In 12 choice sets, participants were asked to choose
between two treatment alternatives. A random parameters logit model was used to analyse the data.
Results: A total of 126 participants, aged 18 years and older, currently or in the previous year in treat-
ment for an anxiety disorder, completed the survey. Respondents preferred short (over long) waiting
times, face-to-face (over digital) treatment, individual (over group) treatment and a treatment intensity
of one session per week rather than two sessions per week or one session every two weeks. Waiting
time and treatment intensity were substantially less important to patients than level of digitalization
and group size. Heterogeneity in preference was significant for each attribute, and sub-group analyses
revealed this was partly related to education level and age.
Limitations: The convenience sample over-represented the female and younger population, limiting
generalizability. Limited information on background characteristics limited the possibilities to explore
preference heterogeneity.
Conclusions: This study demonstrated how different treatment components for anxiety disorders
affect patients’ preferences for those treatments. There is significant variation in treatment preferences,
even after accounting for age and education. Incorporating patients’ preferences into treatment
decisions could potentially lead to improved adherence of treatments for anxiety disorders.
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Anxiety disorders are debilitating disorders1 and are among
the most prevalent of mental disorders worldwide, with a life-
time prevalence of 19.6% in the Netherlands2. In 2009, more
than one million people in the Netherlands within the age
range of 18–64 years were suffering from an anxiety disorder2.
Anxiety disorders substantially reduce the patients’ quality-of-
life3. Research shows that approximately one out of three peo-
ple who suffer from either a mood/anxiety disorder, or have
symptoms of one of these disorders, waits at least a year to
seek professional help4. Not seeking treatment reduces qual-
ity-of-life for a longer period of time, and could result in a lon-
ger time to recovery4. The societal costs of anxiety disorders
are substantial. Anxiety and depressive disorders together
account for 12 billion days of lost productivity every year
worldwide at an estimated cost of US $925 billion5. This means
that anxiety and depressive disorders are amongst the most
prevalent and expensive disorders worldwide6–8.
Different treatments of anxiety disorders have been
shown to be effective9,10. However, uptake and adherence to
treatment is poor, with only one-third of the people with
anxiety disorder seeking help for their problems in the past
year2, resulting in a considerable treatment gap7. A possible
explanation for low uptake rates is stigma surrounding anxi-
ety disorders7, but treatment could also be avoided because
people are not aware that treatment could be helpful11.
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Once in treatment, 20% of patients are estimated to dropout
prematurely12.
Assessing patients’ preferences for treatment modalities
and incorporating them into clinical decision-making might
be a step towards improving uptake rates, optimizing treat-
ment adherence, and decreasing dropout during treat-
ment7,13. Previous preference studies have been conducted
for the treatment of mental disorders13,14. However, these
studies did not specifically target treatment for anxiety disor-
ders, but rather mental disorders in general. A report of the
Netherlands Institute of Mental Health and Addiction con-
cluded that it would be beneficial to better understand the
preferences of patients with anxiety disorders, as this could
reduce the number of protracted care users and the duration
of their symptoms or disorder4.
Discrete-choice experiments (DCE) are increasingly used to
elicit patients’ preferences in healthcare15. A DCE is a question-
naire in which the respondent repeatedly chooses between
hypothetical treatment alternatives16 that differ on several key
characteristics, the so-called attributes (i.e. treatment alterna-
tives differ with regard to the levels of those attributes). A DCE
allows us to elicit the preference of respondents towards, and
to estimate the relative importance of those attributes16, con-
ditional on the range of attribute levels.
The aim of this research was to elicit the preferences of
patients with anxiety disorders for treatment modalities using
a DCE. Understanding patients’ preferences for available
treatment modalities may help clinicians and decision-makers
to optimize treatment, and thereby potentially reduce the
personal and economic burden of anxiety disorders.
Methods
Discrete-choice experiment
We elicited patient preferences using a DCE, a commonly used
method in choice experiments, based on the random utility
theory17. In the DCE, patients were repeatedly offered two
anxiety treatments (treatment A and B) that varied according
to four characteristics (i.e. attributes), and patients were asked
to choose the treatment alternative they preferred.
Attributes and levels
Identifying the relevant attributes and levels is an important
step in generating valid results16,18. PubMed and Google
Scholar were searched for articles on characteristics that are
potentially important in the design of anxiety treatment.
Additionally, we searched for studies in the mental health
field with information on preference and or adherence, see,
for example15,19,20. Seven attributes were identified (waiting
time until first treatment, intensity of the treatment, face to
face vs digital treatment, group size, specialization of the
mental health professional, patient’s own contribution within
the treatment, and effectiveness of treatment). After consul-
tation with two experts in mental health treatment, one cli-
ent representative, and one DCE expert, the number of
attributes was reduced to four (waiting time until first treat-
ment, intensity of the treatment, face-to-face vs digital treat-
ment, and individual vs group treatment), in order to reduce
the complexity of the choice tasks. As we were interested in
treatment modalities, attributes such as efficacy and cost
were not considered. Based on a pre-test with three patients,
the understandability and usefulness of the attributes/levels
was judged to be appropriate. Only minor changes in the
wording of the questionnaire were made. Table 1 shows the
attributes with their corresponding levels.
Experimental design and sample size
A sub-set of the full factorial design was selected for the
study, allowing us to estimate all the relevant parameters,
without needing respondents to assess each possible treat-
ment profile. A Bayesian efficient experimental design was
used to select the treatment profiles using Ngene
(v1.1.1)21,22. A Bayesian efficient design maximizes the preci-
sion of the estimated parameters, by maximizing the D-effi-
ciency, a summary measure of the variance covariance
matrix, for a given number of choice questions. The experi-
mental design used a priori information about patients’ pref-
erences based on expected results (e.g. that shorter waiting
time is preferred over longer waiting time) and consultation
with experts. An example of a choice set is shown in
Figure 1.
Out of the different sources available for determining min-
imum sample size23–25, we started off with the rule of thumb
as suggested by Orme23, defined as 500  (the maximum
number of levels (3))/(the number of choice tasks (12)  the
number of alternatives (2)), indicating that a minimum sam-
ple size of 63 respondents was needed to estimate main
effects. As this rule of thumb is sometimes insufficient, and
to allow for sub-group analyses, we then doubled this
Table 1. Attributes and levels used in DCE.
Attribute Levels Modelled in the indirect utility function
Waiting time until first treatment One week As continuous variable WAITTIME
Four weeks
Eight weeks
Intensity of the treatment Once a week during 8 weeks Omitted category
Twice a week during 4 weeks As categorical variable TWOWEEK
Once per 2 weeks during 16 weeks As categorical variable HALFWEEK
Face-to-face vs digital Face-to-face Omitted category
Digital As categorical variable DIGITAL
Partly face-to-face, partly digital As categorical variable COMBI
Group size Individual Omitted category
Small group (3–5 persons) As categorical variable SMALL
Large group (6–10 persons) As categorical variable LARGE
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sample size, resulting in a targeted sample size of 126
respondents.
Participants, measures, and procedures
Respondents were recruited via social media channels of the
Trimbos Institute and other mental health organizations.
Participants were included if they were currently, or in the
previous 12months, under any kind of treatment for anxiety,
and excluded if they were younger than 18. Prior to entering
the study, participants were informed about the aim and
procedure of the study, after which they needed to provide
consent in order to enter the study.
The main outcome measure of the study was the relative
preference for the attributes and levels defined in the DCE,
which was elicited using 13 choice sets, including one dupli-
cate choice set to assess test–re-test reliability. This number
of choice sets is commonly used in DCEs15 and was further
checked when pre-testing the DCE. The questionnaire eli-
cited self-reported information on demographics, level of
education and depression treatment, and measured patients’
level of perceived impairment during daily activities (i.e.
household, work, and social relationships) on a 1–10 scale,
using the Sheehan Disability Scale (SDS)26.
The questionnaire was administered online via
LimeSurvey27. Patients providing consent to participate and
satisfying eligibility criteria entered the questionnaire. The
questionnaire started with the DCE, which was preceded by a
thorough description of each attribute-level and an example of
a choice task, to promote consistency in participants’ under-
standing of the choice sets. After completion of the choice
sets, respondents were asked to scale the difficulty of the
choice tasks on a five-point Likert scale. The questionnaire
ended with a section on patients’ characteristics, socio-demo-
graphics, treatment history, and perceived level of impairment
Statistical analyses
The DCE provided us with the patient’s preference for each
of the attributes used to describe the treatment profiles in
each choice set. Responses were analysed using the random
utility theory17. The model estimates Vij, the utility that a
patient i assigns to a treatment j. Vij is modelled as the sum
of the utility of each of the attribute levels that make up a
treatment profile, plus an error ԑij, and is specified as:
Vij ¼ b0 þ b1 þ g1ið Þ WAITTIMEj þ b2 þ g2ið Þ TWOWEEKj
þ b3 þ g3ið Þ HALFWEEKj þ b4 þ g4ið Þ DIGITALj
þ b5þg5ið Þ COMBIj þ b6 þ g6ið Þ SMALLj
þ b7 þ g7ið Þ LARGEj þ eij
where waiting time is a continuous variable and all other
variables represent levels of categorical attributes. Waiting
time was modelled as a continuous linear variable, as the fit
of the model (pseudo-R-squared) was better than when
modelling waiting time as a categorical variable, suggesting
that a linear relationship was most appropriate. The constant
b0 was included in the model to test for a systematic prefer-
ence for either treatment A or B. b1 to b7 represent the
mean attribute utility weights and g1 to g7 are error terms
representing individual unexplained variation in utility
weights. Effect coding was used to describe all categorical
attributes (i.e. treatment intensity, face-to-face vs digital
treatment and group size). The levels not included in the
regression analysis for treatment intensity, face to face vs
digital and group size were “once a week”, “face-to-face”,
and “individual”, respectively. They were subsequently esti-
mated from the other levels of the attributes and normalized
towards zero. Using effect coding, the preference weights
are relative to the mean effect of the different levels of the
attributes. The sign of the coefficients indicates whether the
attribute level has a positive or negative effect on treatment
utility compared to the mean. The range of the beta-coeffi-
cients for each attribute was used to estimate the condi-
tional relative importance of each attribute.
A random parameters logit model was fitted to the data
using Nlogit, version 5.028. Within this model, the parameter
for each attribute-level could vary within the sample due to
the specification of the random parameters. The random
parameters for all attributes were drawn from a normal dis-
tribution. The estimation was conducted using 1,000 Halton













Lower occupational 6 4.76%
Higher occupational 42 33.33%
Academic 78 61.90%
Mean Sheehan Disability Scale
7.5 or lower 59 46.83%







 “Besides your current treatment, have you been treated for symptoms of
anxiety before?”
Attribute Treatment A Treatment B
Waiting time until first 
treatment
4 weeks 1 weeks
Intensity of the treatment Once a week during 
eight weeks
Once per two weeks 
during sixteen weeks
Face-to-face vs digital Completely face-to-face Partly face-to-face, 
partly digital
Group size Individual Small group (3-5 
persons)
Which treatment would you 
choose? (Tick one box only) 
Figure 1. Example question of DCE.
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draws29,30. The random parameters logit model shows attrib-
utes for which preference variation is significant. However, it
does not explain why these levels are preferred18. To learn
more about possible variation in preferences, several sub-
group analyses were conducted, taking scale heterogeneity
into account. The sub-group analyses were conducted for
sub-groups defined by age, education level, and level of per-
ceived impairment when suffering from an anxiety disorder.
Sub-groups for each of the three variables were defined by
splitting the sample across the median. To assess significant
differences between sub-groups, joint models were esti-
mated using interaction terms to investigate potential prefer-




The questionnaire was completed by 126 out of 247 partici-
pants that started the questionnaire. The 121 participants
not completing the questionnaire were excluded from the
analysis. The final sample of 126 completers consisted of 13
male (10.3%) and 113 (89.7%) female participants.
Respondents’ characteristics are presented in Table 2.
Respondents rated the difficulty of the DCE task on a five-
point scale (1¼ extremely easy to 5¼ extremely difficult)
with a 2.81 average, which lies between easy (¼ 2) and neu-
tral (¼ 3); 72.2% of the completers rated the questionnaire
as not difficult (score  3). A total of 111 (88.1%) participants
chose the same treatment alternative in the test–re-test
question, suggesting high reliability and consistency in
respondents’ choices.
Patients’ preferences
The main results of the random parameters logit model are
presented in Table 3 and Figure 2. The positive coefficient in
the treatment intensity attribute, and the fact that the 95%
confidence intervals did not overlap shows that respondents
had a preference for treatment once a week compared to
twice a week. Respondents also preferred face-to-face treat-
ment compared to digital treatment. A combination of face-
to-face and digital treatment was preferred over digital treat-
ment only. For the attribute group size, individual treatment
was significantly preferred over treatment in small groups
and large groups and a small group was preferred when
respondents had to choose between a small and a large
group. Lastly, respondents preferred short waiting times. The
non-significant constant indicated there was no systematic
preference for either treatment A or B.
The conditional relative importance for the attributes
face-to-face vs digital (47.2%) and group size (31.8%) was
substantially larger than the conditional relative impor-
tance for waiting time (16.1%) and treatment intensity
(5.0%), indicating that the first two attributes were more
important to respondents when choosing between alter-
native treatment options. Moreover, the results indicate
that patients are willing to accept a combination of face-
to-face and digital treatment instead of face-to-face
treatment alone, if it is accompanied by a 6–7 week
reduction in waiting time (as the loss in utility of 1.68 –
0.44¼ 1.24 is then offset by a gain in utility
of 6.50.19¼ 1.24).
McFadden’s Pseudo R-squared showed a model fit of 0.39,
which can be considered a good fit31. The standard deviation
parameters were statistically significant for all attributes, sug-
gesting significant heterogeneity among the respondents
resulting in variation in the importance of the attribute/level
across respondents.
Table 3. Main results random parameters logit model.
Attributes and levels Estimate (95% CI) p-valuea SD Conditional relative importance
Constant 0.05 (0.14, 0.24) 0.60
Waiting time 16.1%
Per 1 week 0.19 (0.26, 0.13) 0.00 0.16 (0.09, 0.24)
Treatment intensity (reference level: once a week) 0.16 (0.02, 0.34) 5.0%
Twice a week 0.25 (0.43, 0.08) 0.00 0.29 (0.02, 0.59)
Once per 2 weeks 0.09 (0.08, 0.26) 0.29 0.31 (0.01, 0.61)
Face-to-face vs digital (reference level: face-to-face) 1.68 (1.10, 2.26) 47.2%
Digital 2.12 (2.59, 1.64) 0.00 1.36 (1.00, 1.71)
Combination 0.44 (0.25, 0.63) 0.00 0.40 (0.11, 0.68)
Group size (reference level: individual) 1.41 (1.05, 1.77) 31.8%
Small 0.20 (0.38, 0.17) 0.03 0.52 (0.25, 0.79)
Large 1.21 (1.54, 0.88) 0.00 1.03 (0.70, 1.35)
Data presented as estimate (95% CI).


















































































































Figure 2. Main results random parameters logit model with standard deviation.
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Sub-group analyses
In addition to the main analysis, several sub-group analyses
were conducted.
Younger vs older respondents
The results of the model for younger respondents (aged
18–30 years) and older respondents (31 years and older) are
presented in Table 4. The conditional relative importance of
each attribute, indicated by the range in the preference coef-
ficients for each attribute, is shown in Figure 3. Younger
respondents have less preference against digital treatment
compared to older respondents (p¼ 0.01). The analysis sug-
gests there might be more preference against treatment in a
small group in the older sub-group (p¼ 0.06).
Low educated vs high educated respondents
The results of the model for low educated respondents vs
high educated respondents are presented in Table 5. The
conditional relative importance of each attribute, indicated
by the range in the preference coefficients for each attribute,
is shown in Figure 4. Significant differences in preferences
were found within these respondent groups for the waiting
time and the treatment intensity. Higher educated respond-
ents had a significantly stronger preference for shorter wait-
ing times than low educated respondents (p¼ 0.02). Also,
high educated respondents had a significantly stronger pref-
erence against a treatment intensity of twice a week than
low educated respondents (p¼ 0.02).
Respondents with low vs high perceived impairment
The median of the respondents’ mean SDS score had a value
between 7 and 8. Therefore, this sub-group analysis com-
pared respondents with a mean score of 7.5 or lower to
respondents with a mean score of 7.5 or higher. This roughly
divided the sample between those feeling moderately
impaired and those feeling markedly impaired by
their symptoms.
The preference for treatment modalities in people with
lower vs higher impairment are presented in Table 6. The
conditional relative importance of each attribute, indicated
by the range in the preference coefficients for each attribute,
is shown in Figure 5. This sub-group analysis showed the
same preference trends as the main analysis, with no signifi-
cant differences between the two sub-groups.
Discussion
To the best of our knowledge, this is one of the first studies
to elicit preferences with regard to treatment modalities for
patients with an anxiety disorder. Our study shows that
patients with an anxiety disorder prefer a short (over long)
waiting time, face-to-face (over digital) treatment, individual
treatment or a group as small as possible, and treatment
once a week over twice a week or once per 2 weeks. The
choice between face-to-face vs digital treatment was the
Table 4. Differences between older and younger respondents in preferences for anxiety treatment.
Attributes and levels High age Low age p-valuea
Number of patients 74 52
Pseudo-R2 0.45 0.34
Log likelihood 337.43 284.26
Constant 0.18 (0.11, 0.46) 0.12 (0.41, 0.18) 0.17
Waiting time
Per 1 week 0.23 (0.33, 0.13) SD: 0.15 0.16 (0.26, 0.06) SD: 0.24 0.20
Treatment intensity (reference level: once a week) 0.27 (0.06, 0.60) 0.09 (0.17, 0.35)
Twice a week 0.25 (0.54, 0.28) SD: 0.57 0.29 (0.56, 0.03) SD: NS 0.41
Once per 2 weeks 0.02 (0.28, 0.24) SD: 0.48 0.20 (0.05, 0.46) SD: NS 0.21
Face-to-face vs digital (reference level: face-to-face) 2.11 (1.16, 3.06) 1.39 (0.51, 2.27)
Digital 2.56 (3.36, 1.75) SD: 1.27 1.91 (2.62, 1.19) SD: 1.69 0.01
Combination 0.45 (0.18, 0.72) SD: 0.52 0.52 (0.22, 0.82) SD: 0.49 0.71
Group size (reference level: individual) 1.76 (1.12, 2.40) 1.28 (0.70, 2.86)
Small 0.43 (0.70, 0.16) SD: 0.53 0.04 (0.24, 0.32) SD: 0.53 0.06
Large 1.33 (1.88, 0.77) SD: 1.05 1.32 (1.86, 0.77) SD: 1.07 0.44
Data presented as estimate (95% CI).
SD, standard deviation; NS, not significant.
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Figure 3. Sub-group analysis high vs low age.
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most important for respondents, followed by individual vs
group treatment, waiting time and treatment intensity, with
the first two attributes being substantially more important to
patients than the latter two.
We only identified one previous study assessing patients’
preferences for certain anxiety treatment characteristics in a
perinatal population32. This study suggests that costs and
treatment type were the most important characteristics
when choosing a treatment. Because of the differences in
samples and attributes, it is difficult to compare the results
in this study to our own results, although notably no prefer-
ence against online treatment was found in Ride and
Lancsar32. Other studies on patient preferences exist, but
these either used a more qualitative approach33 or did not
focus on mental health specifically34.
Our main analysis showed significant heterogeneity in pref-
erence within our sample. Sub-group analyses found that older
respondents had more preference against digital treatment.
Respondents with lower education were less averse to a longer
waiting time compared to higher educated respondents and,
in addition, were less averse to a more intense treatment.
These insights in variation in preference could potentially
improve clinical practice. By involving patients in the various
choices regarding treatment modalities, patient satisfaction
might be enhanced, and the effectiveness and uptake of treat-
ments might increase. However, the actual impact of providing
treatment more in line with patients’ preferences should be
formally assessed in a randomized controlled trial. The signifi-
cant variation in treatment preference, even within the consid-
ered sub-groups, calls for additional studies on the predictors
for differential treatment preference.
Limitations and future studies
This study has a number of limitations. First, we used online
channels (such as Facebook) for recruitment, which is likely
to have led to a specific sample of potentially more moti-
vated, more chronic, and more e-literate respondents. The
bias towards e-literate respondents is likely to have impacted
preference outcomes regarding digital treatment. This means
our results are limited in their generalizability. This limitation
is further emphasized by the uneven sample distribution of
gender (predominately female) and education (predomi-
nately higher occupational and academic education), which
specifically limits the generalizability of our study to males
and lower-educated patients. In addition, due to the online
data collection method, information was self-reported,
including information on diagnosis, which could have
resulted in bias. Furthermore, we could not assess whether
respondent dropout of the questionnaire further compro-
mised generalizability. Given the considerations regarding
generalizability, it should be noted that an identical study
targeting patients with depression resulted in very simi-
lar results35.
Table 5. Differences between high and low educated in preferences for anxiety treatment.
Attributes and levels High education Low education p-valuea
Number of patients 78 48
Pseudo-R2 0.46 0.33
Log likelihood 348.39 266.14
Constant 0.48 (0.10, 0.85) 0.26 (0.54, 0.02) 0.09
Waiting time
Per 1 week 0.32 (0.46, 0.19) SD: 0.38 0.11 (0.18, 0.03) SD: NS 0.02
Treatment intensity (reference level: once a week) 0.30 (0.01, 0.61) 0.03 (0.24, 0.31)
Twice a week 0.62 (0.98, 0.26) SD: NS 0.02 (0.24, 0.27) SD: 0.37 0.02
Once per 2 weeks 0.32 (0.00, 0.64) SD: 0.46 0.05 (0.30, 0.19) SD: NS 0.17
Face-to-face vs digital (reference level: face-to-face) 2.68 (1.07, 4.29) 1.29 (0.54, 2.04)
Digital 3.35 (4.62, 2.07) SD: 1.97 1.66 (2.26, 1.07) SD: 1.18 0.10
Combination 0.67 (0.25, 1.09) SD: 0.78 0.37 (0.41, 0.06) SD: NS 0.53
Group size (reference level: individual) 2.14 (1.24, 3.04) 1.30 (0.78, 1.82)
Small 0.38 (0.77, 0.02) SD: 1.05 0.17 (0.41, 0.06) SD: 0.33 0.46
Large 1.76 (2.45, 1.07) SD: 1.12 1.13 (1.61, 0.64) SD: 1.08 0.64
Data presented as estimate (95% CI).
SD, standard deviation; NS, not significant.

































































































































































































































Figure 4. Sub-group analysis high vs low education.
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Second, in the background questions we asked the
respondents whether they were previously treated for their
anxiety disorder. However, no questions were asked about
the experience of this previous treatment nor about the type
of treatment they received (e.g. cognitive behavioural ther-
apy, e-health, etc.). Therefore, we could not assess to what
extent the preferences stated in the answers in this study
were affected by the previous treatment of respondents and
respondents’ experiences in those previous treatments. In
general, the limited number of available background
variables in our study limited our ability to explain observed
variation in treatment preference.
Third, the information that was and was not given while
explaining the choice tasks to respondents is likely to have
impacted on their responses. Specifically, it is important to
emphasize that no information was given about the effec-
tiveness of the treatment choices. Cuijpers et al.20 showed
that a higher treatment intensity can lead to improved treat-
ment effectiveness. It is likely that this relationship was not
known by respondents, and disclosing this information could
have changed their preference toward more intensive treat-
ment. Our results, therefore, need to be interpreted as
implicitly incorporating patients’ beliefs about attribute effec-
tiveness. A related limitation is that it is not known to what
extent respondents had a clear and uniform understanding
of each of the considered attributes, which means that, in
the extreme scenario, significant differences found in sub-
group analyses could be reflecting differential understanding
of treatment components, rather than actual differential
preferences.
Fourth, our results on patients’ preferences are limited to
the attributes considered in our choice tasks. Other attrib-
utes, such as the nature of the treatment itself (e.g. pharma-
cological treatment, cognitive behavioural therapy), can be
expected to be very important to patients. As our study
focused on treatment modalities, future studies should also
investigate preferences with regard to treatment cost, treat-
ment effectiveness, or the nature of the treatment. In addi-
tion, the selection of attributes in our study could have
benefitted from a more formal qualitative research approach
to selecting a sub-set of the most relevant attributes with
client experts, where ideally a larger number of experts
would be consulted.
Fifth, no information was known about respondents’ type
of anxiety disorders. It could very well be that patients with
Table 6. Differences between respondents’ preferences with a high and low perceived impairment.
Attributes and levels High SDS Low SDS p-valuea
Number of patients 67 59
Pseudo-R2 0.38 0.43
Log likelihood 347.29 277.85
Constant 0.18 (0.47, 0.10) 0.41 (0.01, 0.80) 0.04
Waiting time
Per 1 week 0.21 (0.30, 0.11) 0.27 (0.42, 0.13) 0.28
SD: 0.19 SD: 0.29
Treatment intensity (reference level: once a week) 0.06 (0.23, 0.35) 0.23 (0.51, 0.05)
Twice a week 0.23 (0.50, 0.03) 0.28 (0.59, 0.02) 0.57
SD: 0.51 SD: NS
Once per 2 weeks 0.17 (0.09, 0.43) 0.05 (0.24, 0.35) 0.64
SD: 0.47 SD: 0.40
Face to face vs digital (reference level: face-to-face) 1.70 (0.66, 2.74) 2.62 (1.58, 3.65)
Digital 2.33 (3.15, 1.52) 2.99 (4.45, 1.53) 0.44
SD: 1.80 SD: 1.66
Combination 0.63 (0.31, 0.95) 0.37 (0.04, 0.71) 0.28
SD: 0.59 SD: 0.52
Group size (reference level: individual) 1.67 (1.05, 2.29) 2.16 (1.54, 2.78)
Small 0.33 (0.61, 0.05) 0.11 (0.44, 0.21) 0.16
SD: 0.65 SD: 0.76
Large 1.34 (1.87, 0.80) 2.05 (3.13, 0.98) 0.27
SD: 1.18 SD: 1.25
Data presented as estimate (95% CI).
SD, standard deviation; NS, not significant.


































































































































































































































Figure 5. Sub-group analysis lower vs higher perceived impairment.
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social phobia have different preferences towards individual
vs group treatment or face-to-face vs digital treatment as
compared to patients with post-traumatic stress disorder or
generalized anxiety disorder. Future studies should try to dis-
tinguish treatment preferences for different types of anxi-
ety disorders.
Sixth, non-significant findings could have been the result
of a limited sample size, especially so in sub-group analyses.
Conclusions
This study showed that patients with an anxiety disorder pre-
fer treatment in a small group or individually, and that they
prefer short waiting times, face-to-face treatment, and one
treatment session per week. Combined face-to-face and digi-
tal treatment could be acceptable when waiting times are
short. Individual and face-to-face treatment is substantially
more important to patients than waiting time and treatment
intensity. Individual-level variation in treatment preference
highlights the need to take individual preferences into
account when choosing a treatment.
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